Table 1 The baseline characteristics of patients before PSM
From: The efficacy of surgery in advanced hepatocellular carcinoma: a cohort study
Characteristics | All patients, no. (%), 1434 (100) | P value | |
|---|---|---|---|
Surgery, 168 (11.7) | Non-surgery, 1266 (88.3) | ||
Gender | 0.363 | ||
Male | 135 (80.4) | 1053 (83.2) | |
Female | 33 (19.6) | 213 (16.8) | |
Age at diagnosis | 0.225 | ||
30–44 | 7 (4.2) | 27 (2.1) | |
45–59 | 72 (42.8) | 499 (39.4) | |
60–74 | 71 (42.3) | 563 (44.5) | |
75–84 | 18 (10.7) | 177 (14) | |
Ethnicity | 0.373 | ||
White | 119 (70.8) | 871 (68.8) | |
Black | 23 (13.7) | 225 (17.8) | |
Others | 26 (15.5) | 170 (13.4) | |
Marital status | 0.022 | ||
Married | 103 (61.3) | 638 (50.4) | |
Single | 57 (33.9) | 571 (45.1) | |
Others | 8 (4.8) | 57 (4.5) | |
AJCC T stage | < 0.001 | ||
T1 | 58 (34.5) | 289 (22.8) | |
T2 | 51 (30.4) | 270 (21.3) | |
T3 | 56 (33.3) | 627 (49.5) | |
T4 | 2 (1.2) | 65 (5.1) | |
TX | 1 (0.6) | 15 (1.2) | |
Year of diagnosis | < 0.001 | ||
2004–2006 | 49 (29.2) | 178 (14.1) | |
2007–2009 | 49 (29.2) | 249 (19.7) | |
2010–2012 | 28 (16.6) | 393 (31) | |
2013–2015 | 42 (25) | 446 (35.2) | |
Tumor size | 0.01 | ||
≤ 3 cm | 38 (22.6) | 181 (14.3) | |
3–5 cm | 39 (23.2) | 274 (21.6) | |
> 5 cm | 91 (54.2) | 811 (64.1) | |
Tumor number | 0.428 | ||
1 | 142 (84.5) | 1104 (87.2) | |
2 | 19 (11.3) | 135 (10.7) | |
3 | 6 (3.6) | 23 (1.8) | |
> 3 | 1 (0.6) | 4 (0.3) | |
Radiotherapy | 0.115 | ||
Yes | 11 (6.5) | 132 (10.4) | |
No | 157 (93.5) | 1134 (89.6) | |
Chemotherapy | 0.046 | ||
Yes | 77 (45.8) | 684 (54) | |
No | 91 (54.2) | 582 (46) | |
Liver resection | 69 | – | – |
Wedge or segmental resection | 27 | – | |
Lobectomy | 25 | – | |
Extended lobectomy | 14 | – | |
Hepatectomy | 3 | – | |
Non-liver resection | 99 | – | – |
Local tumor destruction | 30 | – | |
Cryoablation | 2 | – | |
Percutaneous ethanol injection | 5 | – | |
Radiofrequency ablation | 55 | – | |
Others | 7 | – | |